by telrheum | Sep 11, 2024 | Autoimmune Diseases, anti-CCP, Juvenile Idiopathic Arthritis, Laboratory Testing, Rheumatoid Arthritis
This study explored whether testing for anti-CCP3 antibodies in people who have musculoskeletal (MSK) symptoms but tested negative for anti-CCP2 antibodies could help predict the development of inflammatory arthritis (IA) or rheumatoid arthritis (RA). A total of 469...
by telrheum | Sep 9, 2024 | Autoimmune Diseases, Juvenile Idiopathic Arthritis, Laboratory Testing, Psoriatic Arthritis, Spondyloarthritis, systemic juvenile idiopathic arthritis
The article “Potential Tear-Based Uveitis Biomarkers in Children with JIA: A Pilot Study” explores the possibility of using proteins found in tears to detect uveitis, an eye condition that can occur in children with juvenile idiopathic arthritis (JIA). Uveitis can...
by telrheum | Jun 19, 2024 | Juvenile Idiopathic Arthritis, Rheumatic Drugs, tumour necrosis factor inhibitors (TNFis)
Background: Juvenile idiopathic arthritis (JIA) is a condition in children causing joint inflammation. Etanercept is a common medication for JIA, but the best dose for effectiveness is unclear. This study looks at whether increasing the dose of etanercept helps...
